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Abstract: After finishing a human genome reference sequence in 2002, the genomics 
community has turned to the task of interpreting it. A primary focus is to identify and 
characterize not only protein-coding genes, but all functional elements in the genome. The 
effort includes both individual investigators and large-scale projects like the Encyclopedia 
of DNA Elements (ENCODE) project. As part of the ENCODE project, several groups 
have identified millions of regulatory elements in hundreds of human cell-types using 
DNase-seq and FAIRE-seq experiments that detect regions of nucleosome-free open 
chromatin. ChIP-seq experiments have also been used to discover transcription factor 
binding sites and map histone modifications. Nearly all identified elements are found in 
non-coding DNA, hypothesizing a function for previously unannotated sequence. In this 
review, we provide an overview of the ENCODE effort to define regulatory elements, 
summarize the main results, and discuss implications of the millions of regulatory elements 
distributed throughout the genome. 
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The sequencing of the human genome has both facilitated progress and uncovered new challenges. 
The sequence itself is a trove of data benefiting diverse biological disciplines. Insights enabled by the 
human genome project are fueling the drive toward personalized medicine and impacting the diagnosis 
and treatment of human disease [1]. Though our knowledge has increased considerably, there are many 
unanswered questions. Foremost is the task of converting so much data into meaningful information. 
With the genome sequence in hand, how do we make sense of what it says? Assigning even a basic 
function for the majority of the genome has still not been completed. Despite monumental progress, a 
primary goal remains to determine what the genome actually encodes. 
sequence dates to before the sequencing project began. About 40 years ago, with preliminary evidence, 
Ohno suggested that only 6% of the human genome consists of genes and promoters [2]. He was not 
far off more recent estimates put that number near 2 3% [3,4]. 
 [3]? 
Simply decoding the complete sequence has not answered the question, partly because non-coding 
DNA lacks the information-rich genetic code that has made identifying protein-coding sequences 
possible. However, the community has now amassed experimental evidence that much noncoding, 
intergenic DNA is important for transcriptional regulation. These sequences regulate transcription by 
controlling when a gene is expressed with respect to, for example, cell-type, developmental stage, or 
environment. It is still possible that some of the genome does not have a direct cellular function, such 
as particular repetitive sequences that have not yet been thoroughly explored [4], but it is clear that 
much of the genome is regulatory. This has led to a multifaceted effort to identify and characterize the 
regulatory sequences in the human genome. 
Cataloging regulatory elements is vital for a complete understanding of human biology. Like all 
multicellular organisms, humans are composed of a diverse set of cell-types with widely divergent 
phenotypes that interact in complex ways. The diversity of cellular phenotype is possible because of 
differential gene regulation, despite cells having identical genomes. Each cell-type activates different 
genes via appropriate regulatory elements that encode instructions dictating a cell's response to both 
external and internal stimuli. In an information flowchart, regulatory elements could be considered 
decision-making entities that transfer input information into the organism's response (Figure 1). A 
difference in phenotype or response to stimulus is often driven by differences in gene expression, 
which are in turn governed by regulatory elements. Thus, regulatory element activity can be viewed as 
a genome-based signal that drives differences in phenotype. In order to piece together how humans 
work, we must understand the differences among cell-types, including decoding their specific 
regulatory elements. 
Thanks to recent biotechnology advances, we can now examine regulatory sequences in depth 
genome-wide. Several methods have recently been applied to genome-wide regulatory element 
study [5], including the DNaseI hypersensitivity assay (DHS) [6,7], formaldehyde-assisted isolation of 
regulatory elements (FAIRE) [8], and chromatin immunoprecipitation (ChIP) [9]. Each of these 
experiments has advantages and disadvantages. The ENCODE consortium [10] has recently generated 
massive amounts of data from each of these experiments. To complement this data, it has been and will 




continue to be necessary to develop computational algorithms and tools to aid in its interpretation. 
Such data and analysis have the potential to help us understand how chromatin structure contributes to 
transcription factor binding, gene expression, and ultimately phenotypic differences. In this review, we 
provide an overview of the ENCODE effort to define regulatory elements based on these experiments, 
summarize the general results, and discuss implications of the millions of regulatory elements 
distributed throughout the genome. 
Figure 1. Transcriptional regulation flowchart showing how regulatory elements convert 
input information into phenotype. A variety of internal and external factors alter chromatin 
structure and transcription factor binding. These regulatory inputs control the availability 
of regulatory elements like enhancers, silencers, or promoters. Regulatory elements drive 
gene expression, which ultimately control phenotype (along with other regulatory 
influences like RNA decay). 
 
2. Background 
2.1. Chromatin Structure 
Chromatin structure has long been known to affect tissue-specific transcriptional regulation [11,12]. 
Figure 2 illustrates the familiar organization of DNA in the genome. Briefly, the double helix wraps 
around histone protein octamers to form nucleosomes that then, with additional scaffold proteins, form 
higher-order 30 nm fibers. Transcriptionally silenced regions are generally packaged into tightly-
packed heterochromatin. Actively transcribed genes typically remain in the more loosely-packed 




euchromatin, where DNA is more accessible to the transcriptional machinery. Within euchromatin, 
some stretches of DNA are less associated with histones. These "unwrapped" regions are referred to as 
open, accessible, or nucleosome-depleted regions. Nucleosome-depleted regions can interact with 
DNA-binding proteins, which can then regulate nearby chromatin structure and gene expression. 
Thus, one avenue for chromatin structure to affect transcriptional regulation is through open 
chromatin being bound by sequence-specific transcription factors. Scientists have been studying 
regulatory elements using experiments that locate open chromatin since the 1970s [13]. However, 
despite the realized importance and interest in studying regulatory DNA, initial studies of the human 
genome sequence instead focused on protein-coding genes. This is partly due to difficulties  
with noncoding DNA: Identifying and assigning functions to regulatory elements is complicated by  
several issues. 
Figure 2. Open chromatin and the organization of DNA in a cell. DNA is tightly wound 
around histone proteins to form nucleosomes. Nucleosomes are further wrapped around 
scaffold proteins to form the 30 nm fiber. In unwrapped regions where histones are 
displaced, the DNA is open for recognition by transcription factors. Open chromatin 
regions are also susceptible to DNaseI, which cleaves phosphodiester bonds in the DNA 
backbone to sever DNA molecules. 
 
2.2. Challenges to Studying Regulatory Elements 
What makes studying regulatory elements so difficult? First is the sheer number of elements; there 
are far more than genes. Our initial estimate of 30,000 to 40,000 genes in the human genome [4] has 
more recently been reduced to 20,000 25,000 [14]. In contrast, the number of proposed regulatory 
elements currently stands in the millions and continues to rise [15,16]. This complexity has given rise 
volume of regulatory sequence (perhaps one-third of the genome vs. 2% being coding regions) makes 
it difficult to study [16].  




Second, they are difficult to find. Unlike protein-coding genes, which have a rigid genetic code, 
regulatory elements seem to lack such a rigid code and are thus more difficult to identify 
computationally. Where regulatory elements do follow patterns, such as conforming to transcription 
factor binding motifs, they are more elastic, which has led to more sequence variation in regulatory 
elements than in protein-coding genes. Sequence conservation yields some clues (e.g., [17]), but active 
functional elements may not be under detectable evolutionary constraint [18,19]. For this reason, we 
must currently rely mainly on experimental methods to identify regulatory elements. 
Third, after identifying regulatory elements, further difficulties arise in determining their 
targets [20]. Regulatory elements can act both directly and indirectly to modulate transcriptional levels. 
For direct (or cis-) regulation, target genes are not obvious because an element does not necessarily 
regulate the single nearest gene; instead, they can act at large distances [21], skip genes [22], or affect 
multiple genes [23]. Elements can also act indirectly (in trans-) to affect genes en masse by regulating 
a transcription factor with many targets. These layers form the robust system required to thrive in a 
changing environment, but they are not easy to dissect and explain. 
Fourth, regulatory elements have a variety of functions [24]. For example, there are distinctions 
between promoters, enhancers [25], enhancer blockers [26], insulators [27], LCRs [28], and Polycomb-
bound silencers [29]. One step further, within each category there may be additional subdivisions, such 
as the distinction between TATA-box vs. CpG-rich promoters [30] or enhancer sub-classes [25]. Each 
performs a different but necessary purpose, but the sequence alone is currently unable to classify the 
elements by type. Computational research continues to identify subtle sequence patterns [31], but our 
understanding of sequence remains a key limitation.  
Finally, perhaps the most important challenge to studying transcriptional regulation is that the 
regulome is dynamic. The human regulome varies in many dimensions, such as age, environment, 
developmental time, cell-cycle stage, and tissue type. In contrast, the genome is essentially constant 
and identical in each cell and tissue type. To identify every regulatory element in the human genome is 
a currently infeasible task; it would require interrogating every cell-type under every possible 
developmental stage in any environment and against all genetic backgrounds. 
Despite these challenges, considerable recent progress has been made toward identifying and 
characterizing regulatory elements. Several of these difficulties have only started to become tractable 
in the past few years due in large part to technological improvements in sequencing and computation, 
which have driven new discovery in almost every biological field. In the study of transcriptional 
regulation, the major genome-wide findings have been primarily driven by results from chromatin 
accessibility and transcription factor experiments that assay regulatory elements. 
2.3. Open Chromatin and Regulatory Element Assays 
Three common experimental techniques used to assay chromatin structure and identify regulatory 
elements are DNaseI hypersensitivity (DHS), formaldehyde assisted identification of regulatory 
elements (FAIRE), and chromatin immunoprecipitation (ChIP). These assays each have strengths  
and weaknesses. 




2.3.1. DNaseI Hypersensitivity (DHS) 
Scientists have long used DNaseI hypersensitivity (DHS) assays to distinguish between open 
regions of DNA and those protected from digestion by nucleases [32]. Deoxyribonucleases (DNases) 
are enzymes that cleave phosphodiester bonds in DNA (Figure 2). There are several types of DNases, 
including restriction enzymes, which are sequence-specific DNases. In contrast, DNaseI cleaves  
non-specifically (without sequence preference). DNaseI is a fairly large enzyme, which limits its 
ability to penetrate tight spaces and restricts it to cleaving DNA that is easily accessible. In a DNaseI 
hypersensitivity experiment, DNA is treated with a small concentration of DNaseI. The cuts can then 
be located within the genome and quantified to annotate open chromatin. In the original experiments, 
this was done on individual loci and cuts were mapped using the electrophoretic separation of 
radiolabelled digested fragments on polyacrylamide gels. Now, we use high-throughput sequencing to 
interrogate digestion genome-wide with greater resolution [6]. As a result, after sequencing short DNA 
molecules corresponding to DNaseI cuts and aligning these to a reference sequence, we get a profile of 
that is accessible to DNaseI primarily corresponds to regulatory elements. Since many (probably most) 
changes in the accessibility of DNA are associated with regulatory processes [33], DNaseI assays have 
been the gold standard in locating regulatory elements. One particular advantage of DNaseI 
experiments is that they can detect all types of active elements, even without prior knowledge of 
function [34]; however, they do not identify what specific factors bind there. They simply distinguish 
between open and closed DNA. 
2.3.2. Formaldehyde-assisted Isolation of Regulatory Elements (FAIRE) 
FAIRE is a more recent technique that highlights similar open chromatin regions [8]. It is a 
relatively simple experiment that involves only a few steps: first, a formaldehyde step to fix  
protein-DNA interactions, followed by sonication to fragment the genome, and finally a  
phenol-chloroform extraction to separate bound from unbound DNA. Unbound DNA is then 
sequenced and aligned to identify nucleosome-depleted regions. The results overlap considerably, but 
not completely, with DNaseI regions [35]. The advantages of FAIRE are that it is highly reproducible 
and that the samples require relatively minimal preprocessing, reducing potential artifacts and enabling 
the experiment to be done on a variety of sample types [8]. However, the final signal is more diffuse 
and lacks additional information used for fine-resolution DNaseI footprint mapping [36,37]. 
2.3.3. Chromatin Immunoprecipitation (ChIP) 
Like DHS assays, ChIP dates from several decades ago [38]. In ChIP, like FAIRE, a lysate is cross-
linked to fix protein-DNA reactions, and sonicated or digested to shear the genome. Then, antibodies 
-links are reversed, and DNA is 
sequenced. Two common uses of ChIP are 1) to find where specific factors bind, and 2) to identify 
histone tail modifications. In the first case, ChIP differs from DHS and FAIRE assays in that it targets 
a specific factor. This is both an advantage and a disadvantage; the factor bound is revealed, but it 
requires specific antibodies and individual experiments for each factor of interest. Thus, we can only 




use ChIP on factors that are known a priori. In the second case, ChIP uses antibodies against histone 
proteins (rather than transcription factors), with different antibodies targeting histones with different 
chain modifications. This type of ChIP experiment does not identify individual transcription factors, 
but nucleosomes with particular modifications. This usually results in a much more diffuse signal 
covering multiple nucleosomes; it does not identify specific TFs but it does give a clue as to the 
function of the region because some modifications have been associated with certain types of 
regulatory functions [39]. 
There have been several major advances in ChIP technology recently; most notable is ChIP-seq, the 
combination with sequencing to look at genome-wide TF binding [9]. ChIP has also been recently 
modified to require fewer cells [40], include methylation status [41], and provide better resolution with 
exonucleases [42]. One of the key remaining limitations with ChIP is the availability of high quality 
antibodies [43]. 
2.3.4. Other Similar Assays 
MNase-seq is similar to DNase-seq, but replaces DNaseI with MNase (micrococcal nuclease) [44]. 
The principles of the experiment are the same, but MNase is a smaller molecule than DNaseI, enabling 
it to digest smaller, less accessible areas. It is able to cleave the linker region between nucleosomes. It 
also has exonuclease activity, so it digests back from the initial cuts until it reaches a bound protein 
protecting the DNA. Rather than sequencing where the cuts are, this method sequences the DNA left 
intact, indicating the location where something (a nucleosome or transcription factor) is bound. This 
can highlight exact nucleosome positioning, but it requires deeper sequencing because it sequences the 
inverse regions: locations of nucleosomes, rather than open regions (less than 5% of a genome is open 
in any given DHS experiment [35]). For this reason, it has primarily been used in smaller genomes, 
like yeast, but a limited amount of data from human is also available [44]. Other similar techniques 
include Sono-seq [45] and Nome-seq [46] which also identify open chromatin; Sono-seq uses 
sonication instead of DNaseI to fragment DNA, while Nome-seq uses a methyltransferase to mark 
regions of open chromatin with GC methylation. 
One key limitation of all of the above methods is that the regions they identify are only potentially 
functional. Open chromatin, and even evidence for a bound transcription factor, implies but does not 
demonstrate regulatory potential [24]. It is possible for regions to be open or even bound but still lack 
regulatory effect. Reporter assays are commonly used to validate function, but currently these are done 
on an individual-site basis, limiting the number of sites that can be reasonably tested. 
3. Identifying and Characterizing Regulatory Elements  
The most common experiment among those mentioned above has been ChIP. Several groups in the 
ENCODE Consortium have published the results of hundreds of ChIP experiments for different  
cell-types and transcription factors [10,47]. Recent reviews have summarized these results [48,49]. In 
this review we focus on recent work identifying regulatory elements using DNaseI hypersensitivity and 
FAIRE in the ENCODE project. This work has both confirmed hypotheses formed on smaller samples 
and has revealed new findings regarding how transcriptional regulation works at the genomic 
level [16,35]. 




3.1. Open Chromatin Defines Regulatory Elements 
The working hypothesis of the past several decades has been that open chromatin identifies 
regulatory regions. Genome-wide results now confirm this finding: Thurman et al. [16] showed that 
the DNaseI-seq profile recapitulates the sum of TF ChIP-seq signals. In K562 cells, with ChIP-seq 
results available for more than 42 factors, the correlation between the cumulative ChIP results and 
DNaseI-seq is very high (~0.8). Almost 95% of known ChIP-seq peaks are in regions identified as 
open by DNaseI assays. This result shows that open chromatin is a reasonable proxy for generic TF 
binding and highlights the utility of open chromatin assays. 
3.2. Regulatory Elements are Located in Promoter, Intergenic, and Intronic Regions 
The distribution of DNA in the genome relative to known transcribed regions is shown in Figure 3, 
and compared to the distribution of regulatory elements. The vast majority of regulatory elements are 
noncoding, with about 5% identifying known promoter elements, and the other noncoding elements 
almost evenly split between intergenic and intronic sequences [16]. There are some rare exonic open 
chromatin regions, which could regulate splicing [50], or they may overlap intronic elements. The 
clear emphasis on distal regulation (most elements are intergenic or intronic) supports the growing 
realization that distal elements are a key source of phenotypic complexity [25]. 
3.3. More than 30% of the Genome May be Regulatory 
Using a sample of 126 cell types, Thurman et al. [16] reported that nearly one-third of the genome 
shows sensitivity to DNaseI digestion with ~15% of the genome being DNaseI hypersensitive. These 
percentages differ depending on the threshold used to define hypersensitivity, but they provide an idea 
about the overall proportion of the genome that is sensitive to DNaseI. These numbers should be 
considered minimums, as they are restricted to the cell-types, environments, and developmental stages 
assayed. Figure 4 shows how the number and percentage approaches saturation with increasing  
cell-types. This trend is not simply a result of false-positive DNase-seq signal, which is estimated to be 
less than 0.5% [16]. The numbers will grow as new cell-types and contexts are assayed. Without 
testing all cell-types and contexts, the exact percentage of regulatory DNA in the human genome 
cannot be determined, but these results demonstrate that it may be quite high. Ultimately, these regions 
will have to be tested to establish function. 
3.4. Most Regulatory Elements are Cell-Type-Specific 
With open chromatin data from a variety of cell-types, it is possible to classify regulatory elements 
as cell-type-specific, shared among multiple cell-types, or ubiquitous. This cell-type-specificity 
classification necessarily depends on the cell-types used. Many elements currently considered  
cell-type-specific may turn out to be present in several related but not yet assayed cell-types. 
Nevertheless, highly cell-type-specific sites are likely to retain that feature, though it may be adjusted 
-type- -cell-lineage-  
Gaulton et al. [51] identified thousands of pancreatic-islet-specific FAIRE sites. Song et al. [35] 
used both FAIRE and DNaseI to show similar results in seven other cell-types. These results have 




illustrated that each cell-type is likely to have a unique set of specific open chromatin regions that 
guide specific cell fates and functions, in addition to those shared by other cell-types. Both of  
these studies made two additional observations in relation to cell-type-specificity: First, the  
cell-type-specific DHS sites were associated with cell-type-specific gene expression; and second,  
cell-type-specific regulatory elements tended to cluster with respect to genomic location. 
Most recently, Thurman et al. [16] showed that the majority of DHS sites are found in relatively 
few cell-types, with the distribution depending on the genomic context of the DHS site. For example, 
promoter DHS sites were more likely to be ubiquitous rather than cell-type-specific. 
Figure 3. The distribution of the genome as a whole compared to the distribution of 
regulatory elements with respect to known transcribed regions. Dark bars reflect the 
genomic distribution while the light bars reflect the distribution of regulatory elements in 
four categories: exon, promoter, intron, and intergenic regions. Regulatory elements are 
located near (promoters) or within (introns, exons) known genes at greater frequency than 
would be expected given the genomic distribution. 
 
3.5. Transcription Factor Binding Affects Chromatin Structure 
One way a cell can affect cell-type-specific expression is by creating a cell-type-specific chromatin 
conformation. It is now becoming clear that a large class of regulatory elements is involved in 
establishing cell-type-specific chromatin structure. For example, CTCF sites have many roles affecting 
chromatin accessibility [52]; CTCF is the canonical insulator, but it also can create both active and 
repressive loops [53]. Recent studies have shown that other factors also work by altering chromatin 
structure. Biddie et al. [54] showed that DNaseI-hypersensitive sites, specifically with AP1 binding 
sites, predefine binding sites for GR receptor binding in glucocorticoid cells. Along the same lines, 
Shibata et al. [55] associated AP1 motifs with DNaseI signal differences across primates. Chromatin 
looping is also likely to be regulated by other factors, such as mediator, p300, and cohesin, which work 
together to establish cell-type-specific chromatin structure [56]. These results collectively illustrate the 
important interaction between transcription factors and chromatin structure. 




Figure 4. The cumulative number of bases contained in DNaseI-hypersensitive sites 
according to annotations by Thurman et al. (2012). This plot shows how the total number 
of accessible bases in the genome (y-axis) grows as additional samples (x-axis) are 
considered. Starting with a single sample on the left, the cumulative number of accessible 
bases is calculated by taking the union of the DHS sites from each successive sample. Two 
generally sensitive). Ultimately, greater than 1.2 billion nucleotides are annotated as within 
a DHS hotspot, with over 500 million nucleotides locating within a DHS peak. 
 
3.6. Chromatin Structure Affects Gene Expression 
A connection between transcription factor binding and chromatin structure represents one way a 
cell could regulate gene expression. Recently, Degner et al. [57] drew the connection between 
chromatin and expression in a study that used matched DNaseI-seq, genotype, and expression data 
from a common cell-type in 70 individuals. They identified about 9,000 sites where DNaseI signal 
correlated with genotype, and further showed that, in many cases, the DNaseI difference also correlates 
with gene expression. In a cross-species comparison, Shibata et al. [55] showed that DNaseI 
differences among primates are closely tied to expression differences. These results illustrate how this 
data may be able to inform computational models to predict gene expression, which has been an area 
of interest in other organisms [58 60]. Along these lines, Natajaran et al. [61] built a model to predict 
gene expression from motif analysis and DNaseI signal. They showed that performance improves 
when distal elements are included in the model, highlighting the relevance of distal regulatory sites. 
These results are beginning to unravel the complex interactions between chromatin structure and  
gene expression. 
3.7. Regulatory Elements can be Classified by Factor, Function, or Cell-Type-Specificity 
One of the most important ways to annotate a regulatory element after discovery is to determine 
what factors bind there. The primary experimental tool for such an annotation is ChIP. In the 




ENCODE project, data for hundreds of ChIP experiments have already been made available on the 
UCSC genome browser [47]. These data enable us to identify the frequency and importance of 
individual factors [62 65], as well as explore cooperativity among factors [66]. DNaseI footprinting 
has also been used to propose what factors bind an element [36,37]. These analyses require not only 
experimental data, but appropriate computational algorithms to extract meaningful signal.  
Regulatory elements can also be divided into functional classes (i.e., silencers, promoters, 
enhancers). Some classes, like promoters, are relatively straightforward to positionally and 
functionally define: they lie just upstream of genes and operate on the adjacent gene. Others, like distal 
enhancers, seem to be anywhere and act on anything. In general, all functional classes share the one 
major property that they tend to be found in regions of open chromatin. However, they vary in other 
properties, such as TF binding and histone marks [67]. For example, insulators are often bound by 
CTCF, whereas enhancers are commonly characterized by certain histone marks (H3K4me1 and 
H3K27ac) or cofactors (p300) [39]. Quantifying histone marks therefore gives us a relatively 
straightforward way to provide an initial annotation of regulatory elements genome-wide. 
The ENCODE Consortium and others have been performing ChIP-seq to identify multiple histone 
modifications in several human cell-types. Heintzman et al. [39] showed that enhancer histone marks 
are more often cell-type-specific, in contrast to promoter and insulator marks that are fairly consistent 
across cell-types. As histone mark data have become available from more cell-types, it has become 
possible to extrapolate to elements of unknown class and improve current genome annotation. On the 
basis of this type of data, computational researchers are designing algorithms to characterize regulatory 
elements. For example, Ernst and Kellis [68] designed a Hidden Markov Model to assign categories to 
genomic elements on the basis of their histone modification signatures. Lee et al. [31] trained a 
Support Vector Machine to predict mammalian enhancers from genomic sequence and validated the 
predictions with ChIP and DNaseI data. Classifying regulatory elements by function will be a vital step 
in understanding transcriptional regulation. 
A complementary way to characterize regulatory elements is by cell-type specificity, rather than by 
experimental signature. Thurman et al. [16] used a self-organizing map (a machine learning method) to 
classify regulatory elements based on their open chromatin signal pattern across all cell-types. They 
showed that regulatory elements cluster into a limited number of similar patterns. These kinds of 
classifications will help us derive more meaningful annotations of regulatory elements. By grouping 
elements by patterns, we may be able to leverage information across open chromatin sites to better 
annotate how they act. For instance, we have discovered that many groups of DHS sites with similar 
patterns of accessibility across cell types share common transcription factor motifs suggesting 
similarly bound factors. 
3.8. Perspectives 
Open chromatin experiments have clearly made progress toward their primary goal to identify 
regulatory elements, but identifying them is only the beginning. Regulatory elements are dynamic; 
they drive expression specific to tissue, developmental stage, genetic background, and environment. 
Distal elements in particular often act in very specific contexts. To decode the human genome, 
regulatory elements must not only be identified, but also characterized by context specificity. We have 




described some initial efforts and results in these endeavors; for example, the open chromatin 
experiments described in this review help us characterize regulatory elements by cell-type. By 
combining this with ChIP for histone modifications and transcription factors, we can hypothesize the 
general function of each element; however, we have only begun to assign precise functions. To reveal 
developmental specificity of an enhancer requires a developmental experiment, such as an embryonic 
assay in non-human model organisms, accomplished by tethering enhancer sequences to basal 
promoters [69]. These assays are currently restricted to only certain classes of regulatory elements, and 
this is an area of active research. In addition, we have little data for environmental context and allelic 
background [70]. Collecting data from all these sources of variability is a challenge, but to completely 
understand even a single element, we must characterize it in each context.  
Another key is the question of what genes a particular regulatory element affects. Neither open 
chromatin, nor ChIP, nor even embryonic assays directly answer this question. The current best 
methods to reveal gene targets are chromatin conformation capture [71,72] or ChIA-PET [73] 
experiments. These experiments examine the physical proximity of promoters to regulatory elements. 
This idea is based on the mounting evidence that physical proximity is associated with regulation [74]; 
however, its precise importance remains unclear [75]. In addition, experiments that assay the nuclear 
organization of the genome remain expensive, time-consuming, and difficult to interpret [76]. A 
potential alternative is to leveraging information across cell-types to correlate cell-type- and 
developmental-specificity of distal elements with promoter elements [16] or gene expression [77]. 
However, this method provides only indirect evidence for regulation. Additional research and  
new methods will be necessary before we will be able to accurately identify the targets of  
regulatory elements. 
Although we still have much to learn, the past 40 years have seen phenomenal advances in our 
understanding of how the human genome works. These advancements have been driven by the 
combined effort of both experimental and computational research. Already, there are clear benefits and 
insights derived from our study of transcriptional regulation, as well as other levels of gene regulation, 
including mRNA splicing, dispersion, and decay. As we improve our annotations of regulatory 
elements, our goal to convert this data into information will be realized, ultimately to find the function 
(if present) of what we once called junk DNA. 
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